2004
DOI: 10.1073/pnas.0400148101
|View full text |Cite
|
Sign up to set email alerts
|

Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor α, cyclooxygenase 2, and inflammatory arthritis

Abstract: TIA-1 and TTP are AU-rich element-binding proteins that prevent the pathological overexpression of tumor necrosis factor ␣ (TNF-␣). TIA-1 inhibits the translation of TNF-␣ transcripts, whereas TTP promotes the degradation of TNF-␣ transcripts. Here we show that TIA-1 and TTP function as arthritis suppressor genes: TIA-1 ؊/؊ mice develop mild arthritis, TTP ؊/؊ mice develop severe arthritis, and TIA-1 ؊/؊ TTP ؊/؊ mice develop very severe arthritis. Peritoneal macrophages derived from all three genotypes overexp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
154
0
3

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 180 publications
(163 citation statements)
references
References 27 publications
6
154
0
3
Order By: Relevance
“…Many other mediators of immunity or inflammation are encoded by labile mRNAs that also have adenylate/uridylate-rich elements (AREs) in their 3' UTRs. COX-2, CSF2 and IL-2 genes are dysregulated in the absence of TTP (Carballo et al, 2000;Ogilvie et al, 2005;Phillips et al, 2004), and it seems likely that expression of other inflammatory mediators will also prove to be controlled by TTP. Inflammatory mRNAs can be stabilized via the phosphorylation and inactivation of TTP by MAPK-activated protein kinase 2, a kinase that is activated by p38 MAPK (Carballo et al, 2001;Chrestensen et al, 2004;Stoecklin et al, 2004).…”
Section: Tristetraprolinmentioning
confidence: 99%
“…Many other mediators of immunity or inflammation are encoded by labile mRNAs that also have adenylate/uridylate-rich elements (AREs) in their 3' UTRs. COX-2, CSF2 and IL-2 genes are dysregulated in the absence of TTP (Carballo et al, 2000;Ogilvie et al, 2005;Phillips et al, 2004), and it seems likely that expression of other inflammatory mediators will also prove to be controlled by TTP. Inflammatory mRNAs can be stabilized via the phosphorylation and inactivation of TTP by MAPK-activated protein kinase 2, a kinase that is activated by p38 MAPK (Carballo et al, 2001;Chrestensen et al, 2004;Stoecklin et al, 2004).…”
Section: Tristetraprolinmentioning
confidence: 99%
“…The strain background is known to affect the severity of arthritis in various mouse models (21,22). However, when the DNase II −/− IFN-IR −/− B6 mice were backcrossed to BALB/c mice for five generations, they developed polyarthritis with the same kinetics as the DNase II −/− IFN-IR −/− B6 mice (Fig.…”
Section: Deletion Of the Dnase II Gene In Bone Marrow-derived Cells Cmentioning
confidence: 99%
“…The mRNAs encoding TNFα and GM-CSF are stabilized in TTP-deficient mice and in cells derived from them [9,11]. Excessive levels of these cytokines in TTP knockout mice result in a severe systemic inflammatory response including arthritis, autoimmunity and myeloid hyperplasia [17,18]. On the other hand, up-regulation of TTP reduces inflammatory responses in macrophages [19].…”
Section: Introductionmentioning
confidence: 99%